本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioAge Labs Inc.

8.49
-0.1600-1.85%
盤後8.490.00000.00%19:30 EDT
成交量:67.21萬
成交額:567.86萬
市值:3.90億
市盈率:-3.58
高:8.89
開:8.71
低:8.28
收:8.65
52周最高:25.96
52周最低:4.68
股本:4,589.69萬
流通股本:3,757.56萬
量比:1.61
換手率:1.79%
股息:- -
股息率:- -
每股收益(TTM):-2.3710
每股收益(LYR):-2.2432
淨資產收益率:-28.21%
總資產收益率:-18.47%
市淨率:1.04
市盈率(LYR):-3.78

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/20

重要事件披露

Form 8-K - Current report
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities